STOCK TITAN

MITESCO INC - MITI STOCK NEWS

Welcome to our dedicated page for MITESCO news (Ticker: MITI), a resource for investors and traders seeking the latest updates and insights on MITESCO stock.

Mitesco, Inc. (symbol: MITI) is a development stage company dedicated to consolidating businesses within the compound pharmacy industry, serving human and veterinary markets. Beginning its operations in the Southeast, Mitesco aims to acquire compounders across the United States that align with its mission and vision. The company is committed to unlocking the potential of the compounding pharmacy sector to improve both human and animal health, meet unmet patient needs, enhance the dignity of skilled pharmacists, and build shareholder value through providing quality, cost-effective, and innovative healthcare products and pharmaceuticals worldwide.

Mission: To unlock the potential of the compounding pharmacy industry, improve health outcomes, and provide innovative healthcare solutions while building shareholder value.

Vision: To be globally recognized for best practices in quality, efficiency, and sustainability within the compounding pharmaceutical industry.

Recent Achievements & Current Projects:

  • Full compliance with reporting requirements, including the completion of the Annual Report on Form 10-K.
  • Engagement of Accell Group as their auditor to support compliance and review records effectively.
  • Institutional investors' continued support through 12-month notes to secure funding needs.
  • Ongoing evaluation of the company's capital structure to support both historical and new investors.
  • Formation of a new Advisory Board to assist in evaluating potential acquisition candidates, including both private and publicly held entities.
  • Strategic focus on technology, service, and product business candidates, with a view towards distributing dividends to shareholders from spin-outs.

Financial Condition: Mitesco is actively managing its financial structure, including the termination of a prior stock option program, cancellation of a reverse stock split, and adjustment of restricted stock dividends to protect common stockholders' interests.

Partnerships: Collaboration with Accell Group and support from institutional investors have been crucial in advancing Mitesco's key initiatives and compliance activities.

Future Prospects: With a strategy focused on both organic and acquisition growth, Mitesco aims to leverage its expertise in startups and turnarounds to create successful growth situations. The company is also exploring new initiatives in the data center market and cyber security services, intending to enter commercial, governmental, and utility markets.

Conclusion: Mitesco's dedication to providing high-quality, accessible, and affordable healthcare solutions underscores its potential to become a leading player in the compounding pharmacy industry. By focusing on quality, efficiency, and sustainability, Mitesco is positioned for long-term growth and shareholder value creation.

Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI), a wellness clinic operator, will be presenting at the Benzinga Healthcare Small Cap Conference on September 30, 2021. CEO Larry Diamond is scheduled to deliver a presentation at 4:00 PM ET and will hold one-on-one meetings. Mitesco focuses on expanding The Good Clinic, a network utilizing telehealth technology with nurse practitioners as primary providers, starting in Minneapolis and aiming for nationwide growth. Additionally, Acelerar Healthcare Holdings, based in Dublin, will support future European operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) has signed leases for its fourth Good Clinic location in St. Paul, MN, and its first in Denver, CO. CEO Larry Diamond emphasized the focus on total wellness and personalized healthcare experiences. The new locations are strategically chosen for convenience and community engagement. The Grove development in St. Paul is highly rated, while the Citizen 10 complex in Denver emphasizes city living with various amenities. The Good Clinic aims to leverage telehealth technology, beginning in Minneapolis and planning nationwide expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.45%
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) announced its participation in the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. CEO Larry Diamond will conduct one-on-one meetings with investors during the event. The company's focus is on expanding its wellness clinic operations, particularly through its subsidiary, The Good Clinic, which leverages telehealth technology. Mitesco aims to establish a nationwide network of clinics, with plans for future European operations through Acelerar Healthcare Holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
conferences
Rhea-AI Summary

Mitesco, Inc. (OCTQB: MITI) announces the opening of its second clinic location, The Good Clinic, in Eden Prairie, Minnesota, as part of their expansion plan to establish 50 clinics across multiple states over the next three years. This new site follows the successful launch of their first location in February 2021 and is strategically located within the Elevate residential development.

The clinic aims to offer a range of health services, including primary care and chronic disease management, emphasizing a whole-person wellness approach that has gained positive community response.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) is expanding its The Good Clinic business by opening two new wellness clinics in the Minneapolis area, with the first set to open on September 7, 2021, and the second on September 27, 2021. The new locations will focus on preventive care, behavioral wellness, and chronic disease management, similar to the flagship clinic. Additionally, Mitesco is evaluating nine more locations in the Minneapolis/St. Paul and Denver areas. The expansion aims to enhance healthcare access through nurse practitioners and telehealth technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) announced a partnership with EF Hutton to address its capital needs for clinic expansion and acquisitions. EF Hutton, having raised over $2 billion in 2021, is set to support Mitesco's growth through new site builds and operational needs. Mitesco operates wellness clinics focused on personalized care and technology integration, including The Good Clinic and Acelerar Healthcare Holdings, targeting both North American and European markets. The press release emphasizes their mission to enhance healthcare access and convenience.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) has announced the expansion of The Good Clinic™ management team with Bradley Case as President, aiming to enhance growth through his extensive experience in health care finance and delivery. The clinic plans to implement innovative strategies, including telehealth technology, starting in Minneapolis and expanding nationally. Case's prior leadership roles at SymphonyCare™ and UnitedHealth Group underline his capability to drive operational execution and innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) announced the lease signing for its third The Good Clinic™ location in Eden Prairie, MN, enhancing its expansion strategy in the Minneapolis area. This clinic will join the flagship site opened in February 2021 and another planned in St. Louis Park. The company aims to establish a total of six locations, focusing on a 'whole person' approach to healthcare. CEO Michael Howe emphasized the community's positive reception and the strategic plan for future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.52%
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) announced the appointment of Sheila Schweitzer to its Board of Directors, bringing over 30 years of healthcare experience. Schweitzer has held various leadership roles and founded several healthcare technology companies. CEO Larry Diamond emphasized the importance of integrating technology in enhancing cost-effective healthcare services. Mitesco aims to expand its wellness clinics, with The Good Clinic planning to launch in Minneapolis and nationwide. The company is well-positioned at the intersection of healthcare and technology, focusing on personalized care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
management
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) announced that CEO Larry Diamond will present at the virtual LD Micro Invitational XI investor conference from June 8-10, 2021. The presentation is scheduled for June 10 at 5:00 p.m. EDT on Track 1. Investors can access the live audio webcast via a provided link. Mitesco focuses on operating primary care and wellness clinics, leveraging technology and personalized care. The Good Clinic, a subsidiary of Mitesco, plans to expand its network using telehealth technology, starting in Minneapolis and aiming for nationwide growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences

FAQ

What is the current stock price of MITESCO (MITI)?

The current stock price of MITESCO (MITI) is $0.4 as of December 24, 2024.

What is the market cap of MITESCO (MITI)?

The market cap of MITESCO (MITI) is approximately 3.5M.

What does Mitesco, Inc. do?

Mitesco, Inc. consolidates businesses in the compound pharmacy industry, serving both human and veterinary markets.

Where is Mitesco, Inc. starting its operations?

Mitesco is beginning its operations in the Southeast and intends to acquire compounders across the United States.

What is Mitesco's mission?

Mitesco's mission is to unlock the potential of the compounding pharmacy industry to improve health outcomes and provide innovative healthcare solutions.

Who is Mitesco's new auditor?

Mitesco has engaged the Accell Group as their new auditor.

What recent financial adjustments has Mitesco made?

Mitesco has terminated a prior stock option program, cancelled a reverse stock split, and adjusted restricted stock dividends.

What will Mitesco's new Advisory Board focus on?

The new Advisory Board will assist in evaluating potential acquisition candidates and exploring both private and publicly held entities.

What new market is Mitesco exploring?

Mitesco is exploring new initiatives in the data center market and cyber security services.

How is Mitesco managing its capital structure?

Mitesco is evaluating its capital structure, including securing funding through 12-month notes and considering changes to support all investors.

What is Mitesco's vision?

Mitesco aims to be globally recognized for best practices in quality, efficiency, and sustainability within the compounding pharmaceutical industry.

Who supports Mitesco financially?

Mitesco is supported by institutional investors and has engaged Accell Group for auditing and compliance support.

MITESCO INC

OTC:MITI

MITI Rankings

MITI Stock Data

3.47M
8.09M
10.9%
0.07%
Health Information Services
Healthcare
Link
United States of America
Vero Beach